CJ CGV premieres placement

Korean pharma deal shows value of R&D and brands

Kolmar Korea goes up the value chain with the acquisition of CJ Healthcare to keep one step ahead of potential digital disruption in the sector.

February 21, 2018

Korean biopharma looks for the perfect IPO formula

Expect a slew of biopharmaceutical IPOs from Korea, as companies capitalise on Seoul’s ambition to develop a biotechnology hub. That's if politics doesn't get in the way.

March 13, 2017

Excelsior in block sale of CJ HelloVision shares

Private equity firm Excelsior Capital sells 37% of its stake in South Korea’s largest cable operator CJ HelloVision in a block trade on Thursday night.

February 20, 2014

Netmarble establishes its lineage with IPO pricing

Third largest IPO in Korean history prices at the top of the range, but is still expected to make a solid secondary market debut after amassing strong demand.

April 20, 2017